Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-003399
Filing Date
2022-01-14
Accepted
2022-01-14 20:30:35
Documents
1
Period of Report
2021-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3421
  Complete submission text file 0001209191-22-003399.txt   4811
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Issuer) CIK: 0001718108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SURFACE ONCOLOGY, ICN. 50 HAMPSHIRE STREET 8TH FLOOR CAMBRIDGE MA 02139
Business Address
FEES JESSICA (Reporting) CIK: 0001760391 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38459 | Film No.: 22533299